Kwality Pharmaceuticals Limited reported unaudited standalone and consolidated earnings results for the half year ended September 30, 2017. For the half year, on standalone basis, reported total revenue of INR 619.5 million compared to INR 453.584 million a year ago. Profit from operations before exceptional and extraordinary items and tax was INR 45.409 million compared to INR 20.650 million a year ago. Profit before tax was INR 45.409 million compared to INR 20.650 million a year ago. Profit was INR 30.804 million or INR 5.94 per basic and diluted share compared to INR 15.053 million or INR 2.95 per basic and diluted share a year ago. For the half year, on consolidated basis, reported total revenue of INR 612.516 million compared to INR 462.148 million a year ago. Profit from operations before exceptional and extraordinary items and tax was INR 41.799 million compared to INR 17.814 million a year ago. Profit before tax was INR 41.799 million compared to INR 17.814 million a year ago. Profit was INR 28.963 million or INR 5.58 per basic and diluted share compared to INR 13.607 million or INR 2.67 per basic and diluted share a year ago.